Shiyang Pan
机构:Second Affiliated Hospital of Nanjing Medical University, National Center for Clinical Laboratories, Jiangsu Province Hospital, Nanjing Medical University · ORCID:0000-0001-9320-6988
发表论文 190 篇 · 总被引 3800 次 · h-index 35
代表论文
- Novel insights into IL-37: an anti-inflammatory cytokine with emerging roles in anti-cancer process (2023 · Frontiers in Immunology · 被引 37)
- Single‐cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases (2022 · Clinical and Translational Medicine · 被引 36)
- Molecular identification, antifungal susceptibility, and resistance mechanisms of pathogenic yeasts from the China antifungal resistance surveillance trial (CARST-fungi) study (2022 · Frontiers in Microbiology · 被引 15)
- 860MO MRG003: A novel EGFR-targeted antibody-drug conjugant (ADC) for recurrent/metastatic nasopharyngeal carcinoma (2023 · Annals of Oncology · 被引 12)
- Cellular crosstalk of macrophages and therapeutic implications in non-small cell lung cancer revealed by integrative inference of single-cell transcriptomics (2023 · Frontiers in Pharmacology · 被引 10)
- Results from an IFCC global survey on laboratory practices for the analysis of circulating tumor DNA (2023 · Clinica Chimica Acta · 被引 8)